MAP3K5 and ovarian carcinoma: Interestingly, in ovarian carcinomas, upregulation of PRMT1 expression is associated with an increased methylation of the apoptosis signal-regulated kinase 1 (ASK1), which confers tumor cells with resistance to platinum-based chemotherapeutic agents [160].